Company: RILY
Filing Date: 2025-12-15
Form Type: 10-Q
Source: 0001464790-25-000029
Chunk: 303

Company: B. Riley Financial, Inc.
Filing Date: 2025-12-15
Form: 10-Q
Item: Part I, Item 8
Chunk 303
---
. will not receive any property or distributions under the FRG Plan. As a result, of the FRG Plan, the Company does not expect to receive any proceeds or distributions from the equity investment in Freedom VCM. The bankruptcy filing resulted in the write-off of the equity investment. The change in fair value of $180,964 and $223,369 for the three and six months ended June 30, 2024, respectively, is included in the “Realized and unrealized gains (losses) on investments” line item in the accompanying unaudited condensed consolidated statements of operations.The following tables contain summarized financial information with respect to Freedom VCM, included below for purposes of the disclosure a quarter in arrears (consolidated balance sheet amounts as of September 30, 2024 correspond to amounts as of December 31, 2024 of the Company; income statement amounts during the three and six months ended March 31, 2024 correspond to amounts for the three and six months ended June 30, 2024 of the Company), which is the period in which the most recent financial information was available.September 30, 2024Current assets$871,102 Noncurrent assets$2,889,334 Current liabilities$569,281 Noncurrent liabilities$2,680,178 Equity attributable to investee$510,977 Three Months Ended March 31, 2024Six Months Ended March 31, 2024Revenues$809,717 $1,615,946 Cost of revenues$511,723 $1,011,402 Loss from continuing operations$— $(1,175)Net loss attributable to investees$(19,256)$(118,839)Babcock and Wilcox Enterprises, Inc. Equity InvestmentThe Company owns a 27% voting interest in B&W whereby the Company has elected to account for this investment under the fair value option. The following tables contain summarized financial information with respect to B&W included below for purposes of the disclosure a quarter in arrears (balance sheet amounts as of March 31, 2025 and September 30, 2024 correspond to amounts as of June 30, 2025 and December 31, 2024, respectively, of the Company; income statement amounts during the three and six months ended March 31, 2025 and 2024 correspond to amounts during the three and six months ended June 30, 2025